iShares Edge U.S. Fixed Income Balanced Risk ETF FIBR 深 沪
等待开盘 04-02 09:30:00 美东时间
89.2953
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 89.2953
- 总市值 7590.10万
- 52周最高 87.0204
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 81.0675
- 委 比 0.00%
- 总股本 85.00万
- 历史最高 87.0204
- 量 比 0
- 振 幅 0.00%
- 历史最低 66.12
- 每 手 1
- 风险率 1.26%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-United Therapeutics Corporation Announces Teton-1 Pivotal Study Of Tyvaso® Meets Primary Endpoint For Treatment Of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen In Teton-2
BRIEF-United Therapeutics Corporation Announces Teton-1 Pivotal Study Of Tyvaso® Meets Primary Endpoint For Treatment Of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen In Teton-2 March 30 (Reuters) - United Therapeutics Corp UTHR.O : UNITED THERAPEUTICS CORPORATION ANNOUNC
03-30 21:23
BRIEF-Gyre Therapeutics Announces China’S Nmpa Grants Priority Review To The NDA For Hydronidone (F351) For Chb-Induced Liver Fibrosis Treatment
BRIEF-Gyre Therapeutics Announces China’S Nmpa Grants Priority Review To The NDA For Hydronidone (F351) For Chb-Induced Liver Fibrosis Treatment March 17 (Reuters) - Gyre Therapeutics Inc GYRE.O : GYRE THERAPEUTICS ANNOUNCES CHINA’S NMPA GRANTS PRIORITY REVIEW TO THE NDA FOR HYDRONIDONE (F351) FOR C
03-17 19:51
Garware Technical Fibres Publishes Investor Presentation for Analyst Meet
Garware Technical Fibres Limited ( ($IN:GARFIBRES) ) has shared an announcement...
03-08 17:33
BRIEF-Fibrobiologics, Inc. Announces Issuance Of U.S. Patent Covering Fibroblast Cell Therapy For The Treatment Of Osteoporosis
BRIEF-Fibrobiologics, Inc. Announces Issuance Of U.S. Patent Covering Fibroblast Cell Therapy For The Treatment Of Osteoporosis March 2 (Reuters) - Fibrobiologics Inc FBLG.O : FIBROBIOLOGICS, INC. ANNOUNCES ISSUANCE OF U.S. PATENT COVERING FIBROBLAST CELL THERAPY FOR THE TREATMENT OF OSTEOPOROSIS So
03-02 21:41
Garware Technical Fibres Says Board Non-Compliance Fines Waived by NSE
Garware Technical Fibres Limited ( ($IN:GARFIBRES) ) just unveiled an announcem...
02-28 21:27
BRIEF-Fibra Macquarie México Acquires 124-Hectare Land Parcel Along Tijuana's Boulevard 2000 Submarket
BRIEF-Fibra Macquarie México Acquires 124-Hectare Land Parcel Along Tijuana's Boulevard 2000 Submarket Feb 19 (Reuters) - Fideicomiso Irrevocable No F/1622 FIBRAMQ12.MX : FIBRA MACQUARIE MÉXICO: ACQUISITION OF 124-HECTARE LAND PARCEL ALONG TIJUANA'S BOULEVARD 2000 SUBMARKET FOR US$113.8 MILLION Sour
02-20 07:08
BRIEF-Puretech's Deupirfenidone Receives Orphan Drug Status from US FDA, EU for Pulmonary Fibrosis
BRIEF-Puretech's Deupirfenidone Receives Orphan Drug Status from US FDA, EU for Pulmonary Fibrosis Feb 19 (Reuters) - PureTech Health PLC PRTC.L : PURETECH ANNOUNCES ORPHAN DRUG DESIGNATIONS GRANTED BY THE U.S. FOOD AND DRUG ADMINISTRATION AND EUROPEAN COMMISSION FOR DEUPIRFENIDONE (LYT-100) IN IDIO
02-20 01:37
BRIEF-Digitalbridge Announces Agreement To Sell Its Stake In Netomnia
BRIEF-Digitalbridge Announces Agreement To Sell Its Stake In Netomnia Feb 18 (Reuters) - DigitalBridge Group Inc DBRG.N : DIGITALBRIDGE ANNOUNCES AGREEMENT TO SELL ITS STAKE IN NETOMNIA DIGITALBRIDGE GROUP INC - NETOMNIA TO BE BOUGHT BY NEXFIBRE FOR £2 BILLION DIGITALBRIDGE GROUP INC: TRANSACTION I
02-19 06:58
Krystal Biotech Q4 revenue rises 17.5% driven by VYJUVEK
Krystal Biotech Q4 revenue rises 17.5% driven by VYJUVEK Overview Biotech firm's Q4 product revenue rose to $107.1 mln, driven by VYJUVEK sales Net income for Q4 increased to $51.4 mln Company maintains strong cash position with $955.9 mln in cash and investments Outlook Krystal Biotech expects VYJU
02-17 20:11
BRIEF-Devonian Health Group Inc Reports Positive Results In Pulmonary Fibrosis Study
BRIEF-Devonian Health Group Inc Reports Positive Results In Pulmonary Fibrosis Study Feb 10 (Reuters) - Devonian Health Group Inc GSD.V : DEVONIAN HEALTH GROUP INC: REPORTS POSITIVE RESULTS IN PULMONARY FIBROSIS STUDY DEVONIAN HEALTH GROUP INC - THYKAMINE™ SHOWS BETTER RESULTS THAN PIRFENIDONE IN ST
02-10 23:44
